文献速递耳科与耳神经

梅尼埃病:三十年治疗趋势与证据质量的范围综述

Ménière's Disease: A Tri-Decade Scoping Review of Treatment Trends and Evidence Quality.
PubMed 文献 · Laryngoscope · 2026-04-29

该范围综述系统检索1994-2024年成人梅尼埃病随机对照试验和前瞻性队列研究,评估证据等级与AAO-HNS/CONSORT报告规范性。共纳入257项研究,发现研究数量增加但报告质量下降,治疗转向保留功能为主的干预。

要点

  • 研究量增但AAO-HNS诊断标准依从性仅73%,治疗结局标准依从性仅34%
  • Level 2研究数量翻两番,Level 3研究数量增两倍
  • 管理转向鼓室内激素、MRI可视内淋巴积水、人工耳蜗植入增加

核心结论

  • 梅尼埃病证据基础日益倾向非破坏性、以患者为中心的干预,但报告规范性显著下降威胁证据有效性。

研究设计与样本

  • 范围综述,系统检索PubMed、CINAHL和Cochrane(2014-2024)英文随机对照试验和前瞻性队列研究,纳入成人梅尼埃病患者,共257项研究符合标准。
  • 采用牛津CEBM系统分级证据,使用IBM SPSS v29.0分析指南依从性。

主要发现

  • 从1344篇出版物中纳入257项研究,Level 2研究数量翻两番(p < 0.01),Level 3研究数量增两倍(p < 0.05)。
  • AAO-HNS诊断标准依从性降至73%,治疗结局标准依从性降至34%。
  • 管理转向保留功能干预:内淋巴积水可视MRI、鼓室内激素替代庆大霉素、人工耳蜗植入增加,正压装置使用下降。

关键数值与推荐

  • AAO-HNS诊断标准依从性73%,治疗结局标准依从性34%。
  • Level 2研究数量翻两番(p < 0.01),Level 3研究数量增两倍(p < 0.05)。

临床怎么用

  • 临床可参考鼓室内激素优先于庆大霉素、内淋巴积水MRI和人工耳蜗植入增加的趋势。
  • 需注意治疗结局报告规范性不足,解读证据时谨慎。

局限性

  • 仅检索2014-2024年英文文献,可能遗漏早期或非英文研究。
  • 范围综述设计不提供疗效合并估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ménière's disease (MD) is a complex inner ear disorder defined by endolymphatic hydrops and a triad of episodic vertigo, fluctuating hearing loss, and tinnitus. Despite AAO-HNS diagnostic guidelines, disease heterogeneity and lack of treatment consensus persist. OBJECTIVE: This study conducts a tri-decade scoping review (1994-2024) to evaluate the MD evidence base, shifts in management, and methodological rigor regarding AAO-HNS and CONSORT compliance. MATERIALS AND METHODS: A systematic search of PubMed, CINAHL, and Cochrane (2014-2024) identified English-language RCTs and prospective cohorts involving adults. Studies were graded via the Oxford CEBM system, with guideline compliance analyzed using IBM SPSS v29.0. A scoping review framework was adopted to map the "Quality Paradox" between evidence hierarchy and reporting standards. RESULTS: From 1344 publications, 257 studies met inclusion criteria. While research volume surged-with Level 2 studies quadrupling (p < 0.01) and Level 3 studies tripling (p < 0.05)-reporting standards significantly declined. Adherence to AAO-HNS diagnostic and treatment-outcome criteria dropped to 73% and 34%, respectively. Clinically, management shifted toward preservation-focused interventions, including hydrops-visualizing MRI, intratympanic steroids over gentamicin, and increased cochlear implantation, alongside a decline in positive-pressure device use. CONCLUSION: The MD evidence base increasingly favors non-ablative, patient-centered interventions. However, the validity of these advancements is threatened by a significant decline in reporting compliance. To safeguard the evidence base, journals must enforce standardized reporting as a nonnegotiable prerequisite for publication. LEVEL OF EVIDENCE: N/A.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Zavdy O, Piyajarawong T, Boyle S, et al. Ménière's Disease: A Tri-Decade Scoping Review of Treatment Trends and Evidence Quality. Laryngoscope. 2026. PMID: 42053150. doi:10.1002/lary.70596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。